Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 392

1.

Severe epidemic myalgia with an elevated level of serum interleukin-6 caused by human parechovirus type 3: a case report and brief review of the literature.

Nakamura K, Saito K, Hara Y, Aoyagi T, Kitakawa K, Abe Y, Takemura H, Ikeda F, Kaku M, Kanemitsu K.

BMC Infect Dis. 2018 Aug 7;18(1):381. doi: 10.1186/s12879-018-3284-5.

2.

Metabolic engineering using iterative self-cloning to improve lipid productivity in Coccomyxa.

Kasai Y, Tsukahara T, Ikeda F, Ide Y, Harayama S.

Sci Rep. 2018 Aug 6;8(1):11742. doi: 10.1038/s41598-018-30254-7.

3.

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M.

Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20.

PMID:
30030720
4.

Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.

Seto WK, Asahina Y, Brown TT, Peng CY, Stanciu C, Abdurakhmanov D, Tabak F, Nguyen TT, Chuang WL, Inokuma T, Ikeda F, Santantonio TA, Habersetzer F, Ramji A, Lau AH, Suri V, Flaherty JF, Wang H, Gaggar A, Subramanian GM, Mukewar S, Brunetto MR, Fung S, Chan HL.

Clin Gastroenterol Hepatol. 2018 Jun 19. pii: S1542-3565(18)30633-5. doi: 10.1016/j.cgh.2018.06.023. [Epub ahead of print]

PMID:
29933096
5.

The anti-apoptotic ubiquitin conjugating enzyme BIRC6/BRUCE regulates autophagosome-lysosome fusion.

Ikeda F.

Autophagy. 2018;14(7):1283-1284. doi: 10.1080/15548627.2018.1471311. Epub 2018 Jul 20.

PMID:
29929453
6.

A New Hepatitis Virus Test with Microliter-scale Fingertip Blood Collection in Japan.

Namba S, Ikeda F, Takaguchi K, Shimomura Y, Yasunaka T, Okada H.

Acta Med Okayama. 2018 Jun;72(3):283-287. doi: 10.18926/AMO/56074.

7.

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.

Saragai Y, Takaki A, Umeda Y, Matsusaki T, Yasunaka T, Oyama A, Kaku R, Nakamura K, Yoshida R, Nobuoka D, Kuise T, Takagi K, Adachi T, Wada N, Takeuchi Y, Koike K, Ikeda F, Onishi H, Shiraha H, Nakamura S, Morimatsu H, Ito H, Fujiwara T, Yagi T, Okada H.

BMC Gastroenterol. 2018 May 15;18(1):62. doi: 10.1186/s12876-018-0793-z.

8.

Linear ubiquitin chain-binding domains.

Fennell LM, Rahighi S, Ikeda F.

FEBS J. 2018 Apr 21. doi: 10.1111/febs.14478. [Epub ahead of print] Review.

9.

Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.

Akuta N, Toyota J, Karino Y, Ikeda F, Ido A, Tanaka K, Takaguchi K, Naganuma A, Tomita E, Chayama K, Fujiyama S, Inada Y, Yoshiji H, Watanabe H, Ishikawa H, McPhee F, Noviello S, Kumada H.

J Gastroenterol. 2018 Mar 2. doi: 10.1007/s00535-018-1445-3. [Epub ahead of print]

PMID:
29500489
10.

Transcatheter Arterial Chemoembolization to Reduce Size of Hepatocellular Carcinoma before Radiofrequency Ablation.

Ako S, Nakamura S, Nouso K, Dohi C, Wada N, Morimoto Y, Takeuchi Y, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Shiraha H, Takaki A, Okada H.

Acta Med Okayama. 2018 Feb;72(1):47-52. doi: 10.18926/AMO/55662.

11.

The IAP family member BRUCE regulates autophagosome-lysosome fusion.

Ebner P, Poetsch I, Deszcz L, Hoffmann T, Zuber J, Ikeda F.

Nat Commun. 2018 Feb 9;9(1):599. doi: 10.1038/s41467-018-02823-x.

12.

Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01).

Fujii T, Horiguchi J, Yanagita Y, Koibuchi Y, Ikeda F, Uchida N, Kimura M; GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG).

Anticancer Res. 2018 Feb;38(2):905-909.

PMID:
29374719
13.

Ledipasvir-sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection.

Asahina Y, Itoh Y, Ueno Y, Matsuzaki Y, Takikawa Y, Yatsuhashi H, Genda T, Ikeda F, Matsuda T, Dvory-Sobol H, Jiang D, Massetto B, Osinusi AO, Brainard DM, McHutchison JG, Kawada N, Enomoto N.

Liver Int. 2018 Jan 3. doi: 10.1111/liv.13685. [Epub ahead of print]

PMID:
29297980
14.

One year follow-up after a randomized controlled trial of a 130 g/day low-carbohydrate diet in patients with type 2 diabetes mellitus and poor glycemic control.

Sato J, Kanazawa A, Hatae C, Makita S, Komiya K, Shimizu T, Ikeda F, Tamura Y, Ogihara T, Mita T, Goto H, Uchida T, Miyatsuka T, Ohmura C, Watanabe T, Kobayashi K, Miura Y, Iwaoka M, Hirashima N, Watada H.

PLoS One. 2017 Dec 4;12(12):e0188892. doi: 10.1371/journal.pone.0188892. eCollection 2017.

15.

Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin.

Suzuki L, Kanazawa A, Uzawa H, Osonoi Y, Masuyama A, Azuma K, Takeno K, Takayanagi N, Sato J, Someya Y, Komiya K, Goto H, Mita T, Ikeda F, Ogihara T, Shimizu T, Ohmura C, Saito M, Osonoi T, Watada H.

Expert Opin Pharmacother. 2017 Dec;18(18):1921-1928. doi: 10.1080/14656566.2017.1404576. Epub 2017 Nov 15.

PMID:
29141460
16.

A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data.

Broom BM, Ryan MC, Brown RE, Ikeda F, Stucky M, Kane DW, Melott J, Wakefield C, Casasent TD, Akbani R, Weinstein JN.

Cancer Res. 2017 Nov 1;77(21):e23-e26. doi: 10.1158/0008-5472.CAN-17-0318.

PMID:
29092932
17.

Development and validation of a risk assessment tool for gastric cancer in a general Japanese population.

Iida M, Ikeda F, Hata J, Hirakawa Y, Ohara T, Mukai N, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T.

Gastric Cancer. 2018 May;21(3):383-390. doi: 10.1007/s10120-017-0768-8. Epub 2017 Oct 17.

PMID:
29043529
18.

Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study.

Sato J, Kanazawa A, Azuma K, Ikeda F, Goto H, Komiya K, Kanno R, Tamura Y, Asahara T, Takahashi T, Nomoto K, Yamashiro Y, Watada H.

Sci Rep. 2017 Sep 21;7(1):12115. doi: 10.1038/s41598-017-12535-9.

19.

Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys.

Fujiyuki T, Horie R, Yoneda M, Kuraishi T, Yasui F, Kwon HJ, Munekata K, Ikeda F, Hoshi M, Kiso Y, Omi M, Sato H, Kida H, Hattori S, Kohara M, Kai C.

Sci Rep. 2017 Sep 20;7(1):12017. doi: 10.1038/s41598-017-08326-x.

20.

Intraoral electric potential via oral bacterial power generation -A novel mechanism of biofilm formation.

Kameda T, Oka SY, Morozumi Y, Terada K, Toyama A, Ohkuma K, Kudo M, Ikeda F.

Dent Mater J. 2017 Nov 29;36(6):822-833. doi: 10.4012/dmj.2016-318. Epub 2017 Jul 26.

21.

The P gene of rodent brain-adapted measles virus plays a critical role in neurovirulence.

Arai T, Terao-Muto Y, Uchida S, Lin C, Honda T, Takenaka A, Ikeda F, Sato H, Yoneda M, Kai C.

J Gen Virol. 2017 Jul;98(7):1620-1629. doi: 10.1099/jgv.0.000842. Epub 2017 Jul 15.

PMID:
28708054
22.

NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features.

Horikawa Y, Enya M, Mabe H, Fukushima K, Takubo N, Ohashi M, Ikeda F, Hashimoto KI, Watada H, Takeda J.

Pediatr Diabetes. 2018 Mar;19(2):236-242. doi: 10.1111/pedi.12553. Epub 2017 Jun 30.

PMID:
28664602
23.

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.

Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E.

J Gastroenterol. 2018 Feb;53(2):247-257. doi: 10.1007/s00535-017-1360-z. Epub 2017 Jun 20.

PMID:
28634723
24.

Ubiquitin enzymes in the regulation of immune responses.

Ebner P, Versteeg GA, Ikeda F.

Crit Rev Biochem Mol Biol. 2017 Aug;52(4):425-460. doi: 10.1080/10409238.2017.1325829. Epub 2017 May 19. Review.

25.

Linear ubiquitin chains: enzymes, mechanisms and biology.

Rittinger K, Ikeda F.

Open Biol. 2017 Apr;7(4). pii: 170026. doi: 10.1098/rsob.170026. Review.

26.

Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study.

Maehata Y, Nakamura S, Esaki M, Ikeda F, Moriyama T, Hida R, Washio E, Umeno J, Hirahashi M, Kitazono T, Matsumoto T.

Gut Liver. 2017 Sep 15;11(5):628-634. doi: 10.5009/gnl16357.

27.

Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.

Kanayama S, Okamoto K, Ikeda F, Ishii R, Matsumoto T, Hayashi N, Gotoh N.

J Infect Chemother. 2017 Jun;23(6):374-380. doi: 10.1016/j.jiac.2017.03.004. Epub 2017 Apr 4.

PMID:
28389164
28.

Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin.

Saito D, Kanazawa A, Shigihara N, Sato F, Uchida T, Sato J, Goto H, Miyatsuka T, Ikeda F, Ogihara T, Ohmura C, Watada H.

J Clin Med Res. 2017 Mar;9(3):193-199. doi: 10.14740/jocmr2874w. Epub 2017 Jan 25.

29.

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.

Shimomura Y, Takaki A, Wada N, Yasunaka T, Ikeda F, Maruyama T, Tamaki N, Uchida D, Onishi H, Kuwaki K, Nakamura S, Nouso K, Miyake Y, Koike K, Tomofuji T, Morita M, Yamamoto K, Okada H.

Intern Med. 2017;56(3):243-251. doi: 10.2169/internalmedicine.56.7002. Epub 2017 Feb 1.

30.

Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.

Seki A, Ikeda F, Miyatake H, Takaguchi K, Hayashi S, Osawa T, Fujioka SI, Tanaka R, Ando M, Seki H, Iwasaki Y, Yamamoto K, Okada H.

J Gastroenterol Hepatol. 2017 Sep;32(9):1611-1616. doi: 10.1111/jgh.13746.

PMID:
28114749
31.

Exome sequencing identified RPS15A as a novel causative gene for Diamond-Blackfan anemia.

Ikeda F, Yoshida K, Toki T, Uechi T, Ishida S, Nakajima Y, Sasahara Y, Okuno Y, Kanezaki R, Terui K, Kamio T, Kobayashi A, Fujita T, Sato-Otsubo A, Shiraishi Y, Tanaka H, Chiba K, Muramatsu H, Kanno H, Ohga S, Ohara A, Kojima S, Kenmochi N, Miyano S, Ogawa S, Ito E.

Haematologica. 2017 Mar;102(3):e93-e96. doi: 10.3324/haematol.2016.153932. Epub 2016 Dec 1. No abstract available.

32.

Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.

Wada N, Takaki A, Ikeda F, Yasunaka T, Onji M, Nouso K, Nakatsuka A, Wada J, Koike K, Miyahara K, Shiraha H, Yamamoto K, Okada H.

Hepatol Int. 2017 Jan;11(1):115-124. doi: 10.1007/s12072-016-9773-y. Epub 2016 Nov 8.

PMID:
27826704
33.

Linear ubiquitination by LUBEL has a role in Drosophila heat stress response.

Asaoka T, Almagro J, Ehrhardt C, Tsai I, Schleiffer A, Deszcz L, Junttila S, Ringrose L, Mechtler K, Kavirayani A, Gyenesei A, Hofmann K, Duchek P, Rittinger K, Ikeda F.

EMBO Rep. 2016 Nov;17(11):1624-1640. Epub 2016 Oct 4.

34.

Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.

Matsunami K, Nishida N, Kaneko N, Ikeo K, Toyo-Oka L, Takeuchi H, Matsuura K, Tamori A, Nomura H, Yoshiji H, Imamura M, Masaki N, Hayakawa T, Ide T, Shimada N, Ikeda F, Hino K, Nishiguchi S, Okuse C, Nojiri S, Sawamoto K, Tokunaga K, Joh T, Tanaka Y.

PLoS One. 2016 Oct 10;11(10):e0164418. doi: 10.1371/journal.pone.0164418. eCollection 2016.

35.

The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.

Tortola L, Nitsch R, Bertrand MJM, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, Hanada T, Takahashi N, Kernbauer E, Demiröz D, Lang M, Superti-Furga G, Decker T, Pichler A, Ikeda F, Kroemer G, Vandenabeele P, Sorensen PH, Penninger JM.

Cell Rep. 2016 Sep 20;16(12):3414. doi: 10.1016/j.celrep.2016.08.072. Epub 2016 Sep 20. No abstract available.

36.

Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma.

Nouso K, Kariyama K, Nakamura S, Oonishi A, Wakuta A, Oyama A, Ako S, Dohi C, Wada N, Morimoto Y, Takeuchi Y, Kuwaki K, Onishi H, Ikeda F, Shiraha H, Takaki A, Okada H.

J Gastroenterol Hepatol. 2017 Mar;32(3):695-700. doi: 10.1111/jgh.13586.

PMID:
27597181
37.

Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.

Toyota J, Karino Y, Suzuki F, Ikeda F, Ido A, Tanaka K, Takaguchi K, Naganuma A, Tomita E, Chayama K, Fujiyama S, Inada Y, Yoshiji H, Watanabe H, Ishikawa H, Hu W, McPhee F, Linaberry M, Yin PD, Swenson ES, Kumada H.

J Gastroenterol. 2017 Mar;52(3):385-395. doi: 10.1007/s00535-016-1245-6. Epub 2016 Aug 9.

PMID:
27502287
38.

Infectious Progression of Canine Distemper Virus from Circulating Cerebrospinal Fluid into the Central Nervous System.

Takenaka A, Sato H, Ikeda F, Yoneda M, Kai C.

J Virol. 2016 Sep 29;90(20):9285-92. doi: 10.1128/JVI.01337-16. Print 2016 Oct 15.

39.

A randomized controlled trial of 130 g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control.

Sato J, Kanazawa A, Makita S, Hatae C, Komiya K, Shimizu T, Ikeda F, Tamura Y, Ogihara T, Mita T, Goto H, Uchida T, Miyatsuka T, Takeno K, Shimada S, Ohmura C, Watanabe T, Kobayashi K, Miura Y, Iwaoka M, Hirashima N, Fujitani Y, Watada H.

Clin Nutr. 2017 Aug;36(4):992-1000. doi: 10.1016/j.clnu.2016.07.003. Epub 2016 Jul 18.

PMID:
27472929
40.

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer.

Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M.

Onco Targets Ther. 2016 Jul 7;9:4113-20. doi: 10.2147/OTT.S104140. eCollection 2016.

41.

Inhibition of CBLB protects from lethal Candida albicans sepsis.

Wirnsberger G, Zwolanek F, Asaoka T, Kozieradzki I, Tortola L, Wimmer RA, Kavirayani A, Fresser F, Baier G, Langdon WY, Ikeda F, Kuchler K, Penninger JM.

Nat Med. 2016 Aug;22(8):915-23. doi: 10.1038/nm.4134. Epub 2016 Jul 18.

PMID:
27428901
42.

Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris.

Nakajima A, Ikeda F, Kanayama S, Okamoto K, Matsumoto T, Ishii R, Fujikawa A, Takei K, Kawashima M.

J Med Microbiol. 2016 Aug;65(8):745-50. doi: 10.1099/jmm.0.000293. Epub 2016 Jun 15.

PMID:
27305898
43.

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.

Ikeda F, Shikata K, Hata J, Fukuhara M, Hirakawa Y, Ohara T, Mukai N, Nagata M, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T.

J Epidemiol. 2016 Dec 5;26(12):629-636. Epub 2016 Jun 4.

44.

The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.

Tortola L, Nitsch R, Bertrand MJM, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, Hanada T, Takahashi N, Kernbauer E, Demiröz D, Lang M, Superti-Furga G, Decker T, Pichler A, Ikeda F, Kroemer G, Vandenabeele P, Sorensen PH, Penninger JM.

Cell Rep. 2016 May 17;15(7):1481-1492. doi: 10.1016/j.celrep.2016.04.032. Epub 2016 May 5. Erratum in: Cell Rep. 2016 Sep 20;16(12 ):3414.

45.

Development of new therapy for canine mammary cancer with recombinant measles virus.

Shoji K, Yoneda M, Fujiyuki T, Amagai Y, Tanaka A, Matsuda A, Ogihara K, Naya Y, Ikeda F, Matsuda H, Sato H, Kai C.

Mol Ther Oncolytics. 2016 Jan 13;3:15022. doi: 10.1038/mto.2015.22. eCollection 2016.

46.

In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.

Kanayama S, Ikeda F, Okamoto K, Nakajima A, Matsumoto T, Ishii R, Amano A, Matsuzaki K, Matsumoto S.

J Infect Chemother. 2016 Oct;22(10):720-3. doi: 10.1016/j.jiac.2016.03.006. Epub 2016 Apr 16.

PMID:
27091753
47.

Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma.

Uchida D, Takaki A, Ishikawa H, Tomono Y, Kato H, Tsutsumi K, Tamaki N, Maruyama T, Tomofuji T, Tsuzaki R, Yasunaka T, Koike K, Matsushita H, Ikeda F, Miyake Y, Shiraha H, Nouso K, Yoshida R, Umeda Y, Shinoura S, Yagi T, Fujiwara T, Morita M, Fukushima M, Yamamoto K, Okada H.

Free Radic Res. 2016 Jul;50(7):732-43. doi: 10.3109/10715762.2016.1172071. Epub 2016 Apr 25.

PMID:
27021847
48.

An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis.

Nastase MV, Zeng-Brouwers J, Frey H, Hsieh LT, Poluzzi C, Beckmann J, Schroeder N, Pfeilschifter J, Lopez-Mosqueda J, Mersmann J, Ikeda F, Iozzo RV, Dikic I, Schaefer L.

Am J Pathol. 2016 May;186(5):1206-20. doi: 10.1016/j.ajpath.2015.12.026. Epub 2016 Mar 8.

PMID:
26968342
49.

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.

Yasunaka T, Ikeda F, Wada N, Morimoto Y, Fujioka S, Toshimori J, Kobashi H, Kariyama K, Morimoto Y, Takayama H, Seno T, Takaguchi K, Moriya A, Miyatake H, Okamoto R, Yabushita K, Takaki A, Yamamoto K.

Acta Med Okayama. 2016;70(1):1-12.

50.

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Nakatsuka A, Matsuyama M, Yamaguchi S, Katayama A, Eguchi J, Murakami K, Teshigawara S, Ogawa D, Wada N, Yasunaka T, Ikeda F, Takaki A, Watanabe E, Wada J.

Sci Rep. 2016 Feb 17;6:21721. doi: 10.1038/srep21721.

Supplemental Content

Support Center